These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 27725315)

  • 1. Cardiac actions of fibroblast growth factor 23.
    Faul C
    Bone; 2017 Jul; 100():69-79. PubMed ID: 27725315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of fibroblast growth factor 23 and Klotho in uremic cardiomyopathy.
    Grabner A; Faul C
    Curr Opin Nephrol Hypertens; 2016 Jul; 25(4):314-24. PubMed ID: 27219043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy.
    Grabner A; Amaral AP; Schramm K; Singh S; Sloan A; Yanucil C; Li J; Shehadeh LA; Hare JM; David V; Martin A; Fornoni A; Di Marco GS; Kentrup D; Reuter S; Mayer AB; Pavenstädt H; Stypmann J; Kuhn C; Hille S; Frey N; Leifheit-Nestler M; Richter B; Haffner D; Abraham R; Bange J; Sperl B; Ullrich A; Brand M; Wolf M; Faul C
    Cell Metab; 2015 Dec; 22(6):1020-32. PubMed ID: 26437603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats.
    Leifheit-Nestler M; Grabner A; Hermann L; Richter B; Schmitz K; Fischer DC; Yanucil C; Faul C; Haffner D
    Nephrol Dial Transplant; 2017 Sep; 32(9):1493-1503. PubMed ID: 28339837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor 23 (FGF23) induces ventricular arrhythmias and prolongs QTc interval in mice in an FGF receptor 4-dependent manner.
    Graves JM; Vallejo JA; Hamill CS; Wang D; Ahuja R; Patel S; Faul C; Wacker MJ
    Am J Physiol Heart Circ Physiol; 2021 Jun; 320(6):H2283-H2294. PubMed ID: 33929896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease.
    Leifheit-Nestler M; Große Siemer R; Flasbart K; Richter B; Kirchhoff F; Ziegler WH; Klintschar M; Becker JU; Erbersdobler A; Aufricht C; Seeman T; Fischer DC; Faul C; Haffner D
    Nephrol Dial Transplant; 2016 Jul; 31(7):1088-99. PubMed ID: 26681731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGF23/FGFR4-mediated left ventricular hypertrophy is reversible.
    Grabner A; Schramm K; Silswal N; Hendrix M; Yanucil C; Czaya B; Singh S; Wolf M; Hermann S; Stypmann J; Di Marco GS; Brand M; Wacker MJ; Faul C
    Sci Rep; 2017 May; 7(1):1993. PubMed ID: 28512310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble α-klotho and heparin modulate the pathologic cardiac actions of fibroblast growth factor 23 in chronic kidney disease.
    Yanucil C; Kentrup D; Campos I; Czaya B; Heitman K; Westbrook D; Osis G; Grabner A; Wende AR; Vallejo J; Wacker MJ; Navarro-Garcia JA; Ruiz-Hurtado G; Zhang F; Song Y; Linhardt RJ; White K; Kapiloff MS; Faul C
    Kidney Int; 2022 Aug; 102(2):261-279. PubMed ID: 35513125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotective Effects of Paricalcitol Alone and in Combination With FGF23 Receptor Inhibition in Chronic Renal Failure: Experimental and Clinical Studies.
    Czaya B; Seeherunvong W; Singh S; Yanucil C; Ruiz P; Quiroz Y; Grabner A; Katsoufis C; Swaminathan S; Abitbol C; Rodriguez-Iturbe B; Faul C; Freundlich M
    Am J Hypertens; 2019 Jan; 32(1):34-44. PubMed ID: 30329020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease.
    Singh S; Grabner A; Yanucil C; Schramm K; Czaya B; Krick S; Czaja MJ; Bartz R; Abraham R; Di Marco GS; Brand M; Wolf M; Faul C
    Kidney Int; 2016 Nov; 90(5):985-996. PubMed ID: 27457912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGF21-FGFR4 signaling in cardiac myocytes promotes concentric cardiac hypertrophy in mouse models of diabetes.
    Yanucil C; Kentrup D; Li X; Grabner A; Schramm K; Martinez EC; Li J; Campos I; Czaya B; Heitman K; Westbrook D; Wende AR; Sloan A; Roche JM; Fornoni A; Kapiloff MS; Faul C
    Sci Rep; 2022 May; 12(1):7326. PubMed ID: 35513431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGF23-Mediated Activation of Local RAAS Promotes Cardiac Hypertrophy and Fibrosis.
    Böckmann I; Lischka J; Richter B; Deppe J; Rahn A; Fischer DC; Heineke J; Haffner D; Leifheit-Nestler M
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23.
    Yu X; Ibrahimi OA; Goetz R; Zhang F; Davis SI; Garringer HJ; Linhardt RJ; Ornitz DM; Mohammadi M; White KE
    Endocrinology; 2005 Nov; 146(11):4647-56. PubMed ID: 16081635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The FGFR D3 domain determines receptor selectivity for fibroblast growth factor 21.
    Gupte J; Yang L; Wu X; Weiszmann J; Hecht R; Lemon B; Lindberg R; Wang Z; Li Y
    J Mol Biol; 2011 May; 408(3):491-502. PubMed ID: 21392510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF-23 signaling and regulating FGF-23 expression in bone.
    Wöhrle S; Bonny O; Beluch N; Gaulis S; Stamm C; Scheibler M; Müller M; Kinzel B; Thuery A; Brueggen J; Hynes NE; Sellers WR; Hofmann F; Graus-Porta D
    J Bone Miner Res; 2011 Oct; 26(10):2486-97. PubMed ID: 21812026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different thresholds of fibroblast growth factors pattern the ventral foregut into liver and lung.
    Serls AE; Doherty S; Parvatiyar P; Wells JM; Deutsch GH
    Development; 2005 Jan; 132(1):35-47. PubMed ID: 15576401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localisation and differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal and atherosclerotic human arteries.
    Hughes SE
    Cardiovasc Res; 1996 Sep; 32(3):557-69. PubMed ID: 8881516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paracrine Effects of FGF23 on the Heart.
    Leifheit-Nestler M; Haffner D
    Front Endocrinol (Lausanne); 2018; 9():278. PubMed ID: 29892269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells.
    Antoine M; Wirz W; Tag CG; Mavituna M; Emans N; Korff T; Stoldt V; Gressner AM; Kiefer P
    Growth Factors; 2005 Jun; 23(2):87-95. PubMed ID: 16019430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the fibroblast growth factor receptor (FGFR) signalling network with heparin as coreceptor: evidence for the expansion of the core FGFR signalling network.
    Xu R; Rudd TR; Hughes AJ; Siligardi G; Fernig DG; Yates EA
    FEBS J; 2013 May; 280(10):2260-70. PubMed ID: 23441759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.